S. Koarada

The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients.

Takuya Inoue, K. Kai, Y. Tada, 2018, Rheumatology.

Antifibrotic effects of hepatocyte growth factor on scleroderma fibroblasts and analysis of its mechanism

Y. Tada, I. Ozaki, A. Ohta, 2006, Modern rheumatology.

Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy

T. Morio, K. Kamachi, H. Ureshino, 2020, International Journal of Hematology.

High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis.

T. Nakazono, Y. Tada, S. Hayashi, 2008, The Journal of rheumatology.

Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma.

Y. Tada, N. Suzuki, O. Ushiyama, 2003, The Journal of rheumatology.

Nocardiosis in adult-onset Still's disease and vasculitis syndrome.

H. Inoue, Y. Tada, M. Fukuoka, 2008, The American journal of the medical sciences.